Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Grossman

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of Neuro-Oncology|October 21, 2023
Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastomaRoy Strowd, Benjamin Ellingson, Catalina Raymond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Evaluation of the Safety and Benefit of Phase I Oncology Trials for Patients With Primary CNS TumorsMrinal M Gounder, Lakshmi Nayak, Solmaz Sahebjam, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2025
Low-Dose Fractionated Radiation Therapy as a Chemopotentiator of Temozolomide for Recurrent Anaplastic Astrocytoma and Glioblastoma: A Single-Arm Phase 1/2 TrialTimothy Lin, Suqi Ke, Chen Hu, et al.
Neuro-Oncology|October 16, 2025
Phase I/II and Window-of-Opportunity Study of Pamiparib and Metronomic Temozolomide for Recurrent IDH Mutant GliomasDavid Schiff, Xiaobu Ye, Jing Li, et al.
Neuro-Oncology|May 27, 2015
A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastomaElizabeth R Gerstner, Xiaobu Ye, Dan G Duda, et al.
Journal of Neuro-Oncology|December 29, 2022
ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449Andrew E Sloan, Charles J Nock, Xiaobu Ye, et al.
Frontiers in Immunology|September 30, 2024
Radiation immunodynamics in patients with glioblastoma receiving chemoradiationLindsey Sloan, Rupashree Sen, Chunnan Liu, et al.
Journal of Neuro-Oncology|January 25, 2017
Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomasLakshmi Nayak, John de Groot, Jeffrey S Wefel, et al.
Neuro-Oncology|January 25, 2020
Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patientsEudocia Q Lee, Michael Weller, Joohee Sul, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Neuro-Oncology|October 21, 2023
Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastomaRoy Strowd, Benjamin Ellingson, Catalina Raymond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Evaluation of the Safety and Benefit of Phase I Oncology Trials for Patients With Primary CNS TumorsMrinal M Gounder, Lakshmi Nayak, Solmaz Sahebjam, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2025
Low-Dose Fractionated Radiation Therapy as a Chemopotentiator of Temozolomide for Recurrent Anaplastic Astrocytoma and Glioblastoma: A Single-Arm Phase 1/2 TrialTimothy Lin, Suqi Ke, Chen Hu, et al.
Neuro-Oncology|October 16, 2025
Phase I/II and Window-of-Opportunity Study of Pamiparib and Metronomic Temozolomide for Recurrent IDH Mutant GliomasDavid Schiff, Xiaobu Ye, Jing Li, et al.
Neuro-Oncology|May 27, 2015
A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastomaElizabeth R Gerstner, Xiaobu Ye, Dan G Duda, et al.
Journal of Neuro-Oncology|December 29, 2022
ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449Andrew E Sloan, Charles J Nock, Xiaobu Ye, et al.
Frontiers in Immunology|September 30, 2024
Radiation immunodynamics in patients with glioblastoma receiving chemoradiationLindsey Sloan, Rupashree Sen, Chunnan Liu, et al.
Journal of Neuro-Oncology|January 25, 2017
Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomasLakshmi Nayak, John de Groot, Jeffrey S Wefel, et al.
Neuro-Oncology|January 25, 2020
Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patientsEudocia Q Lee, Michael Weller, Joohee Sul, et al.
Pageof 3